156 related articles for article (PubMed ID: 24449209)
21. Multifaceted functions of B cells in chronic hepatitis C virus infection.
Mondelli MU
Antiviral Res; 2003 Oct; 60(2):111-5. PubMed ID: 14638406
[TBL] [Abstract][Full Text] [Related]
22. Immunoglobulin gene mutations and frequent use of VH1-69 and VH4-34 segments in hepatitis C virus-positive and hepatitis C virus-negative nodal marginal zone B-cell lymphoma.
Marasca R; Vaccari P; Luppi M; Zucchini P; Castelli I; Barozzi P; Cuoghi A; Torelli G
Am J Pathol; 2001 Jul; 159(1):253-61. PubMed ID: 11438472
[TBL] [Abstract][Full Text] [Related]
23. Characterization of humoral and cell-mediated immune responses directed against hepatitis C virus F protein in subjects co-infected with hepatitis C virus and HIV-1.
Troesch M; Jalbert E; Canobio S; Boulassel MR; Routy JP; Bernard NF; Bruneau J; Lapointe N; Boucher M; Soudeyns H
AIDS; 2005 May; 19(8):775-84. PubMed ID: 15867491
[TBL] [Abstract][Full Text] [Related]
24. Primary, post-primary and non-specific immunoglobulin M responses in HCV infection.
Dustin LB; Charles ED
Antivir Ther; 2012; 17(7 Pt B):1449-52. PubMed ID: 23322600
[TBL] [Abstract][Full Text] [Related]
25. Hepatitis C virus, B-cell proliferation and lymphomas.
Gasparotto D; De Re V; Boiocchi M
Leuk Lymphoma; 2002 Apr; 43(4):747-51. PubMed ID: 12153160
[TBL] [Abstract][Full Text] [Related]
26. Splenic lymphoma with villous lymphocytes, mixed cryoglobulinemia and HCV infection: deciphering the role of HCV in B-cell lymphomagenesis.
Suarez F; Lefrere F; Besson C; Hermine O
Dig Liver Dis; 2007 Sep; 39 Suppl 1():S32-7. PubMed ID: 17936220
[TBL] [Abstract][Full Text] [Related]
27. Hepatitis C virus infection and cryoglobulinaemia.
Lunel F; Musset L
Forum (Genova); 1998; 8(1):95-103. PubMed ID: 9514994
[TBL] [Abstract][Full Text] [Related]
28. IgG1 and IgG4 antibodies against Core and NS3 antigens of hepatitis C virus.
Santos VCD; Schinoni MI; Oliveira IS; Atta MLS; Atta AM
Rev Soc Bras Med Trop; 2019 Mar; 52():e20180491. PubMed ID: 30843970
[TBL] [Abstract][Full Text] [Related]
29. Anti-hepatitis C virus core IgM antibodies correlate with hepatitis C recurrence and its severity in liver transplant patients.
Bizollon T; Ahmed SN; Guichard S; Chevallier P; Adham M; Ducerf C; Baulieux J; Trepo C
Gut; 2000 Nov; 47(5):698-702. PubMed ID: 11034588
[TBL] [Abstract][Full Text] [Related]
30. Antibody V(h) repertoire differences between resolving and chronically evolving hepatitis C virus infections.
Racanelli V; Brunetti C; De Re V; Caggiari L; De Zorzi M; Leone P; Perosa F; Vacca A; Dammacco F
PLoS One; 2011; 6(9):e25606. PubMed ID: 21980500
[TBL] [Abstract][Full Text] [Related]
31. HCV and HGV in B-cell non-Hodgkin's lymphoma.
Ellenrieder V; Weidenbach H; Frickhofen N; Michel D; Prümmer O; Klatt S; Bernas O; Mertens T; Adler G; Beckh K
J Hepatol; 1998 Jan; 28(1):34-9. PubMed ID: 9537861
[TBL] [Abstract][Full Text] [Related]
32. Novel human SR-BI antibodies prevent infection and dissemination of HCV in vitro and in humanized mice.
Lacek K; Vercauteren K; Grzyb K; Naddeo M; Verhoye L; Słowikowski MP; Fafi-Kremer S; Patel AH; Baumert TF; Folgori A; Leroux-Roels G; Cortese R; Meuleman P; Nicosia A
J Hepatol; 2012 Jul; 57(1):17-23. PubMed ID: 22414763
[TBL] [Abstract][Full Text] [Related]
33. Sequential changes of hepatitis C virus antibody profiles during treatment of chronic hepatitis C of genotype 1b: pretreatment antibody response to E2/NS1 correlated sustained response.
Chu CM; Sheen IS; Liaw YF
Infection; 2004 Jun; 32(3):153-6. PubMed ID: 15188075
[TBL] [Abstract][Full Text] [Related]
34. Genetic variability of hepatitis C virus non-structural protein 3 and virus-specific CD8+ response in patients with chronic hepatitis C.
López-Labrador FX; He XS; Berenguer M; Cheung RC; González-Candelas F; Wright TL; Greenberg HB
J Med Virol; 2004 Apr; 72(4):575-85. PubMed ID: 14981760
[TBL] [Abstract][Full Text] [Related]
35. Human recombinant single-chain antibody fragments, specific for the hypervariable region 1 of hepatitis C virus, from immune phage-display libraries.
Zhai W; Davies J; Shang DZ; Chan SW; Allain JP
J Viral Hepat; 1999 Mar; 6(2):115-24. PubMed ID: 10607222
[TBL] [Abstract][Full Text] [Related]
36. Contribution of genes for killer cell immunoglobulin-like receptors (KIR) to the susceptibility to chronic hepatitis C virus infection and to viremia.
Kuśnierczyk P; Mozer-Lisewska I; Zwolińska K; Kowala-Piaskowska AE; Bura M; Bereszyńska I; Pauli A; Żeromski J
Hum Immunol; 2015 Mar; 76(2-3):102-8. PubMed ID: 25636579
[TBL] [Abstract][Full Text] [Related]
37. Repertoire and Neutralizing Activity of Antibodies Against Hepatitis C Virus E2 Peptide in Patients With Spontaneous Resolution of Hepatitis C.
Olbrich A; Wardemann H; Böhm S; Rother K; Colpitts CC; Wrensch F; Baumert TF; Berg T; Benckert J
J Infect Dis; 2019 Aug; 220(7):1209-1218. PubMed ID: 31165162
[TBL] [Abstract][Full Text] [Related]
38. Hepatitis C virus (HCV)-related cryoglobulinemia: cryoglobulin type and anti-HCV profile.
Minopetrou M; Hadziyannis E; Deutsch M; Tampaki M; Georgiadou A; Dimopoulou E; Vassilopoulos D; Koskinas J
Clin Vaccine Immunol; 2013 May; 20(5):698-703. PubMed ID: 23467778
[TBL] [Abstract][Full Text] [Related]
39. [Humoral response to hepatitis C virus antigens in coinfection with human immunodeficiency virus type 1].
Nikolaeva LI; Zverev SIa; Petrova EV; Samokhvalov EI; Al'khovskiĭ SV; Tokmalaev AK; Kazennova EV; Bobkova MR
Klin Lab Diagn; 2008 Jul; (7):42-4. PubMed ID: 18756735
[TBL] [Abstract][Full Text] [Related]
40. Significance of IgM anti-HCV core level in chronic hepatitis C.
Papatheodoridis GV; Delladetsima JK; Katsoulidou A; Sypsa V; Albrecht M; Michel G; Hatzakis A; Tassopoulos NC
J Hepatol; 1997 Jul; 27(1):36-41. PubMed ID: 9252071
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
